BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 34946037)

  • 1. High-Fructose Diet Alters Intestinal Microbial Profile and Correlates with Early Tumorigenesis in a Mouse Model of Barrett's Esophagus.
    Proaño-Vasco A; Baumeister T; Metwaly A; Reitmeier S; Kleigrewe K; Meng C; Gigl M; Engleitner T; Öllinger R; Rad R; Steiger K; Anand A; Strangmann J; Thimme R; Schmid RM; Wang TC; Quante M
    Microorganisms; 2021 Nov; 9(12):. PubMed ID: 34946037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Fat Diet Accelerates Carcinogenesis in a Mouse Model of Barrett's Esophagus via Interleukin 8 and Alterations to the Gut Microbiome.
    Münch NS; Fang HY; Ingermann J; Maurer HC; Anand A; Kellner V; Sahm V; Wiethaler M; Baumeister T; Wein F; Einwächter H; Bolze F; Klingenspor M; Haller D; Kavanagh M; Lysaght J; Friedman R; Dannenberg AJ; Pollak M; Holt PR; Muthupalani S; Fox JG; Whary MT; Lee Y; Ren TY; Elliot R; Fitzgerald R; Steiger K; Schmid RM; Wang TC; Quante M
    Gastroenterology; 2019 Aug; 157(2):492-506.e2. PubMed ID: 30998992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-inflammatory chemoprevention attenuates the phenotype in a mouse model of esophageal adenocarcinoma.
    Baumeister T; Ingermann J; Marcazzan S; Fang HY; Oellinger R; Rad R; Engleitner T; Kleigrewe K; Anand A; Strangmann J; Schmid RM; Wang TC; Quante M
    Carcinogenesis; 2021 Aug; 42(8):1068-1078. PubMed ID: 33878160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration of the esophageal microbiota in Barrett's esophagus and esophageal adenocarcinoma.
    Lv J; Guo L; Liu JJ; Zhao HP; Zhang J; Wang JH
    World J Gastroenterol; 2019 May; 25(18):2149-2161. PubMed ID: 31143067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary Fructose Alters the Composition, Localization, and Metabolism of Gut Microbiota in Association With Worsening Colitis.
    Montrose DC; Nishiguchi R; Basu S; Staab HA; Zhou XK; Wang H; Meng L; Johncilla M; Cubillos-Ruiz JR; Morales DK; Wells MT; Simpson KW; Zhang S; Dogan B; Jiao C; Fei Z; Oka A; Herzog JW; Sartor RB; Dannenberg AJ
    Cell Mol Gastroenterol Hepatol; 2021; 11(2):525-550. PubMed ID: 32961355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic High-Fat Diet Induces Early Barrett's Esophagus in Mice through Lipidome Remodeling.
    Molendijk J; Nguyen TM; Brown I; Mohamed A; Lim Y; Barclay J; Hodson MP; Hennessy TP; Krause L; Morrison M; Hill MM
    Biomolecules; 2020 May; 10(5):. PubMed ID: 32429496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to TNF-α Is Increasing Along with the Progression in Barrett's Esophagus.
    Chemnitzer O; Götzel K; Maurer L; Dietrich A; Eichfeld U; Lyros O; Jansen-Winkeln B; Hoffmeister A; Gockel I; Thieme R
    Dig Dis Sci; 2017 Dec; 62(12):3391-3401. PubMed ID: 29086334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elimination of NF-κB signaling in Vimentin+ stromal cells attenuates tumorigenesis in a mouse model of Barrett's Esophagus.
    Anand A; Fang HY; Mohammad-Shahi D; Ingermann J; Baumeister T; Strangmann J; Schmid RM; Wang TC; Quante M
    Carcinogenesis; 2021 Apr; 42(3):405-413. PubMed ID: 33068426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrin stimulates a cholecystokinin-2-receptor-expressing cardia progenitor cell and promotes progression of Barrett's-like esophagus.
    Lee Y; Urbanska AM; Hayakawa Y; Wang H; Au AS; Luna AM; Chang W; Jin G; Bhagat G; Abrams JA; Friedman RA; Varro A; Wang KK; Boyce M; Rustgi AK; Sepulveda AR; Quante M; Wang TC
    Oncotarget; 2017 Jan; 8(1):203-214. PubMed ID: 27448962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial Composition of the Human Upper Gastrointestinal Tract Microbiome Is Dynamic and Associated with Genomic Instability in a Barrett's Esophagus Cohort.
    Gall A; Fero J; McCoy C; Claywell BC; Sanchez CA; Blount PL; Li X; Vaughan TL; Matsen FA; Reid BJ; Salama NR
    PLoS One; 2015; 10(6):e0129055. PubMed ID: 26076489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary interventions to prevent high-fructose diet-associated worsening of colitis and colitis-associated tumorigenesis in mice.
    Nishiguchi R; Basu S; Staab HA; Ito N; Zhou XK; Wang H; Ha T; Johncilla M; Yantiss RK; Montrose DC; Dannenberg AJ
    Carcinogenesis; 2021 Jun; 42(6):842-852. PubMed ID: 33513602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Microbiota in Esophageal Adenocarcinoma: Pathogenesis, Diagnosis, Prognosis and Therapeutic Implications.
    Dan W; Peng L; Yan B; Li Z; Pan F
    Front Microbiol; 2021; 12():791274. PubMed ID: 35126331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Esophageal microbiome signature in patients with Barrett's esophagus and esophageal adenocarcinoma.
    Lopetuso LR; Severgnini M; Pecere S; Ponziani FR; Boskoski I; Larghi A; Quaranta G; Masucci L; Ianiro G; Camboni T; Gasbarrini A; Costamagna G; Consolandi C; Cammarota G
    PLoS One; 2020; 15(5):e0231789. PubMed ID: 32369505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations to the Esophageal Microbiome Associated with Progression from Barrett's Esophagus to Esophageal Adenocarcinoma.
    Snider EJ; Compres G; Freedberg DE; Khiabanian H; Nobel YR; Stump S; Uhlemann AC; Lightdale CJ; Abrams JA
    Cancer Epidemiol Biomarkers Prev; 2019 Oct; 28(10):1687-1693. PubMed ID: 31466948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia.
    Parasa S; Vennalaganti S; Gaddam S; Vennalaganti P; Young P; Gupta N; Thota P; Cash B; Mathur S; Sampliner R; Moawad F; Lieberman D; Bansal A; Kennedy KF; Vargo J; Falk G; Spaander M; Bruno M; Sharma P
    Gastroenterology; 2018 Apr; 154(5):1282-1289.e2. PubMed ID: 29273452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local Synthesis of Pepsin in Barrett's Esophagus and the Role of Pepsin in Esophageal Adenocarcinoma.
    Samuels T; Hoekzema C; Gould J; Goldblatt M; Frelich M; Bosler M; Lee SH; Johnston N
    Ann Otol Rhinol Laryngol; 2015 Nov; 124(11):893-902. PubMed ID: 26077392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host factors influence Barrett's carcinogenesis: findings from a mouse gastroduodenal reflux model.
    Kanai S; Mukaisho KI; Yoshida S; Taniura N; Sugihara H
    Esophagus; 2019 Jul; 16(3):264-271. PubMed ID: 30790117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma.
    Yen CJ; Izzo JG; Lee DF; Guha S; Wei Y; Wu TT; Chen CT; Kuo HP; Hsu JM; Sun HL; Chou CK; Buttar NS; Wang KK; Huang P; Ajani J; Hung MC
    Cancer Res; 2008 Apr; 68(8):2632-40. PubMed ID: 18413730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression profiles of cancer stem cell markers: CD133, CD44, Musashi-1 and EpCAM in the cardiac mucosa-Barrett's esophagus-early esophageal adenocarcinoma-advanced esophageal adenocarcinoma sequence.
    Mokrowiecka A; Veits L; Falkeis C; Musial J; Kordek R; Lochowski M; Kozak J; Wierzchniewska-Lawska A; Vieth M; Malecka-Panas E
    Pathol Res Pract; 2017 Mar; 213(3):205-209. PubMed ID: 28216140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Fat-High Fructose Diet-Induced Changes in the Gut Microbiota Associated with Dyslipidemia in Syrian Hamsters.
    Horne RG; Yu Y; Zhang R; Abdalqadir N; Rossi L; Surette M; Sherman PM; Adeli K
    Nutrients; 2020 Nov; 12(11):. PubMed ID: 33233570
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.